EXICURE, INC. Increase (Decrease) in Accounts Receivable
EXICURE, INC. (XCUR) reported Increase (Decrease) in Accounts Receivable of -$1.34 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-03-25
- EXICURE, INC. increase (decrease) in accounts receivable for the quarter ending 2022-12-31 was $0.00.
- EXICURE, INC. increase (decrease) in accounts receivable for the quarter ending 2022-09-30 was $0.00.
- EXICURE, INC. increase (decrease) in accounts receivable for the quarter ending 2022-06-30 was $0.00.
- EXICURE, INC. increase (decrease) in accounts receivable for the quarter ending 2022-03-31 was $0.00.
- EXICURE, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$1.34M, a 365.22% decline from fiscal 2024.
- EXICURE, INC. increase (decrease) in accounts receivable for fiscal 2024 was $506.00K.
- EXICURE, INC. increase (decrease) in accounts receivable for fiscal 2023 was $0.00.
- EXICURE, INC. increase (decrease) in accounts receivable for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$1.34M 10-K · filed 2026-03-25 | |||
| 2024-12-31 | $506.00K 10-K · filed 2026-03-25 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-18 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $0.00 derived: sum of 2 quarters · filed 2023-03-27 | $0.00 derived: sum of 3 quarters · filed 2023-03-27 | $0.00 10-K · filed 2023-03-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-03-27 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $0.00 derived: sum of 3 quarters · filed 2023-03-27 | $0.00 derived: sum of 4 quarters · filed 2023-03-27 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-27 | $0.00 derived: sum of 3 quarters · filed 2023-03-27 | $0.00 derived: sum of 4 quarters · filed 2023-03-27 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $0.00 derived: sum of 2 quarters · filed 2023-03-27 | $0.00 derived: sum of 3 quarters · filed 2023-03-27 | -$11.00K 10-K · filed 2023-03-27 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | -$11.00K 10-Q · filed 2022-11-14 | -$45.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$11.00K 10-Q · filed 2022-08-15 | -$45.00K derived: sum of 3 quarters · filed 2022-08-15 | -$24.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$11.00K 10-Q · filed 2022-05-16 | -$45.00K derived: sum of 2 quarters · filed 2022-05-16 | -$24.00K derived: sum of 3 quarters · filed 2022-05-16 | -$37.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | -$13.00K derived: sum of 2 quarters · filed 2022-03-25 | -$26.00K derived: sum of 3 quarters · filed 2022-03-25 | -$24.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | $8.00K derived: sum of 2 quarters · filed 2021-11-19 | $10.00K 10-Q · filed 2021-11-19 | |
| 2020-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$11.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |